Data disclosure in Zambia

Presentation by Owas Mwape, MeTA Zambia Council Member during the country sharing meeting, London 2009.

Owas Mwape Council Member Data Disclosure in Zambia MeTA 18/01/10

Type of data being collected ,[object Object],[object Object],[object Object],[object Object],[object Object],18/01/10 MeTA

Overview of disclosure process and engagement of stakeholders ,[object Object],[object Object],[object Object],[object Object],18/01/10 MeTA

Challenges & lessons Learned ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],18/01/10 MeTA

Type of support needed ,[object Object],[object Object],18/01/10 MeTA

Thank you! ,[object Object],[object Object],[object Object],18/01/10 MeTA

To carry on the discussion in real life, join us at Telehealth and Secrets to Success Conference, Sept 20-22, Silicon Valley: https://goo.gl/95zHZG For more information of the webinar such as recording and transcript, please visit: https://vsee.com/blog/tips-jumpstart-telemedicine-program-addiction/ For other webinars: https://vsee.com/webinars/ Or join our Linkedin Group: https://www.linkedin.com/groups/Telehealth-Failures-Secrets-Success-13500037/about Or Join our Facebook Group: https://www.facebook.com/groups/tfssgroup/?ref=group_cover

US Goverment Accountability Office Telehealth report

VSee

2o OTC & Cosmetics Conference, Dr. Peter Smith

digital_health_2020_overviewWill Reedy

Mysupportbroker 6.3.14In-Control Partnerships

31737999_HC Webinar Series_Antitrust_Presentation_05132015Katherine Funk

Health Data Exchange:. Still a Pipe Dream? A Presentation from 2009

David Lee Scher, MD

Mp 1Lord Reza

Data disclosure in Ghana

Me Ta Private Sector Meeting 23 June 2009

What's hot

MeTA priorities and milestones in Zambia

Georgians for a Healthy Future

Getting What You Pay For - Consumer Protections for Network Adequacy and Prov...

Havana Atm

wleereveld

The Role of Technology in Transforming Primary Care

NHS England

Medicines Transparency Kyrgyzstan

2o OTC & Cosmetics Conference, Raymond Anderson

OECD Directorate for Financial and Enterprise Affairs

Neurorehabilitation Summit Presentation

Lee Aase

Regulation and competition in light of digitalisation – US Federal Trade Comm...

Building public trust in the use of health and care data

Health and Care Innovation Expo

Penka Georgieva, "together with you", Bulgaria

Cittadinanzattiva onlus

2o OTC & Cosmetics Conference, Daphné Lecomte-Somaggio

7DayServices self assessment tool

NHS Improving Quality

Tips to jumpstart your telemedicine program for addiction

VSee

US Goverment Accountability Office Telehealth report

VSee

2o OTC & Cosmetics Conference, Dr. Peter Smith

digital_health_2020_overviewWill Reedy

Mysupportbroker 6.3.14In-Control Partnerships

31737999_HC Webinar Series_Antitrust_Presentation_05132015Katherine Funk

Health Data Exchange:. Still a Pipe Dream? A Presentation from 2009

David Lee Scher, MD

Mp 1Lord Reza

What's hot (20)

MeTA priorities and milestones in Zambia

Getting What You Pay For - Consumer Protections for Network Adequacy and Prov...

Havana Atm

The Role of Technology in Transforming Primary Care

Medicines Transparency Kyrgyzstan

2o OTC & Cosmetics Conference, Raymond Anderson

Neurorehabilitation Summit Presentation

Regulation and competition in light of digitalisation – US Federal Trade Comm...

Building public trust in the use of health and care data

Penka Georgieva, "together with you", Bulgaria

2o OTC & Cosmetics Conference, Daphné Lecomte-Somaggio

7DayServices self assessment tool

Tips to jumpstart your telemedicine program for addiction

US Goverment Accountability Office Telehealth report

2o OTC & Cosmetics Conference, Dr. Peter Smith

digital_health_2020_overview

Mysupportbroker 6.3.14

31737999_HC Webinar Series_Antitrust_Presentation_05132015

Health Data Exchange:. Still a Pipe Dream? A Presentation from 2009

Mp 1

Similar to Data disclosure in Zambia

Data disclosure in Ghana

Me Ta Private Sector Meeting 23 June 2009

MeTA and data disclosure

MeTA: Overview and lessons learned in pilot countries

MeTA: Overview and lessons learned in pilot countries

MeTA priorities and milestones in Uganda

Medicines Transparency in Jordan

Medicines Transparency Alliance : helping markets work for the poor

CSO and MeTA

Priorities and milestones – The Philippines

Concept and structure of MeTA

Uganda MeTa Launch 27 Mar09 Brian Elliot

CSO & media orientation workshop

Data disclosurein Kyrgyzstan

EFPIA Disclosure & Consent Management

qordata

Bancroft Research In ActionMEASURE Evaluation

Thailand Oral Care Market Analysis Sample Report

Insights10

Thailand's over-the-counter (OTC) pharmaceuticals market size was valued at $137.5 Mn in 2022 and is estimated to expand at a CAGR of 5.36% from 2022 to 2030 and will reach $208.8 Mn in 2030. OTC are non-prescription medications and are a vital component of the healthcare system, offering consumers accessible solutions for a wide range of common health issues. The market is segmented by product type and distribution channel. To get a detailed report, contact us at - info@insights10.com

Challenges to improve medicines transparency in Ghana

Joint ART/PMTCT Guideline Review Process in KenyaElizabeth Glaser Pediatric AIDS Foundation

Reach frauke uekermanSUN_Movement

Similar to Data disclosure in Zambia (20)

Data disclosure in Ghana

Me Ta Private Sector Meeting 23 June 2009

MeTA and data disclosure

MeTA: Overview and lessons learned in pilot countries

MeTA priorities and milestones in Uganda

Medicines Transparency in Jordan

Medicines Transparency Alliance : helping markets work for the poor

CSO and MeTA

Priorities and milestones – The Philippines

Concept and structure of MeTA

Uganda MeTa Launch 27 Mar09 Brian Elliot

CSO & media orientation workshop

Data disclosurein Kyrgyzstan

EFPIA Disclosure & Consent Management

Bancroft Research In Action

Thailand Oral Care Market Analysis Sample Report

Challenges to improve medicines transparency in Ghana

Joint ART/PMTCT Guideline Review Process in Kenya

Reach frauke uekerman

Recently uploaded

Role of Mukta Pishti in the Management of Hyperthyroidism

Dr. Jyothirmai Paindla

Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx

Superficial & Deep Fascia of the NECK.pptx

A Classical Text Review on Basavarajeeyam

Dr. Jyothirmai Paindla

Physiology of Chemical Sensation of smell.pdf

Title: Sense of Smell Presenter: Dr. Faiza, Assistant Professor of Physiology Qualifications: MBBS (Best Graduate, AIMC Lahore) FCPS Physiology ICMT, CHPE, DHPE (STMU) MPH (GC University, Faisalabad) MBA (Virtual University of Pakistan) Learning Objectives: Describe the primary categories of smells and the concept of odor blindness. Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction. Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain. Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential. Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes. Key Topics: Olfactory Genes: 3% of the human genome accounts for olfactory genes. 400 genes for odorant receptors. Olfactory Membrane: Located in the superior part of the nasal cavity. Medially: Folds downward along the superior septum. Laterally: Folds over the superior turbinate and upper surface of the middle turbinate. Total surface area: 5-10 square centimeters. Olfactory Mucosa: Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell. Sustentacular Cells: Produce mucus and maintain ionic and molecular environment. Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months. Bowman’s Gland: Secretes mucus. Stimulation of Olfactory Cells: Odorant dissolves in mucus and attaches to receptors on olfactory cilia. Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve. Quality of a Good Odorant: Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble. Facilitated by odorant-binding proteins in mucus. Membrane Potential and Action Potential: Resting membrane potential: -55mV. Action potential frequency in the olfactory nerve increases with odorant strength. Adaptation Towards the Sense of Smell: Rapid adaptation within the first second, with further slow adaptation. Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system. Primary Sensations of Smell: Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid. Odor Detection Threshold: Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm). Some toxic substances are odorless at lethal concentrations. Characteristics of Smell: Odor blindness for single substances due to lack of appropriate receptor protein. Behavioral and emotional influences of smell. Transmission of Olfactory Signals: From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition. Primitive, less old, and new olfactory systems with different path

New Drug Discovery and Development .....

NEHA GUPTA

The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.

Knee anatomy and clinical tests 2024.pdf

vimalpl1234

The Electrocardiogram - Physiologic Principles

These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram. Learning objectives: 1. Define an electrocardiogram (ECG) and electrocardiography 2. Describe how dipoles generated by the heart produce the waveforms of the ECG 3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II) 4. Differentiate between intervals and segments 5. Enlist some common indications for obtaining an ECG 6. Describe the flow of current around the heart during the cardiac cycle 7. Discuss the placement and polarity of the leads of electrocardiograph 8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained 9. Define mean electrical vector (axis) of the heart and give the normal range 10. Define the mean QRS vector 11. Describe the axes of leads (hexagonal reference system) 12. Comprehend the vectorial analysis of the normal ECG 13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation 14. Explain the concepts of current of injury, J point, and their significance Study Resources: 1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition 2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition 3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition 4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/ 5. ECG in Medical Practice by ABM Abdullah, 4th edition 6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/ 7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics

Pictures of Superficial & Deep Fascia.ppt.pdf

Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun

chandankumarsmartiso

Sex determination from mandible pelvis and skull

ShashankRoodkee

Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx

Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS

AkankshaAshtankar

ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx

Swetaba Besh

Aortic Association CBL Pilot April 19 – 20 Bern

suvadeepdas911

Non-respiratory Functions of the Lungs.pdf

These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract. Learning objectives: 1. Enlist the non-respiratory functions of the respiratory tract 2. Briefly explain how these functions are carried out 3. Discuss the significance of dead space 4. Differentiate between minute ventilation and alveolar ventilation 5. Describe the cough and sneeze reflexes Study Resources: 1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition 2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition 3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition 4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874

Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists

Saeid Safari

ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS

Dr. Vinay Pareek

Physiology of Special Chemical Sensation of Taste